IE
HOWL icon

Israel Englander’s Werewolf Therapeutics HOWL Stock Holding History

Israel Englander’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.3K Sell
62,055
-69,995
-53% -$42.6K ﹤0.01% 5684
2026
Q1 		$110K Sell
132,050
-108,059
-45% -$74K ﹤0.01% 5323
2025
Q4 		$152K Sell
240,109
-76,944
-24% -$93.5K ﹤0.01% 5544
2025
Q3 		$625K Sell
317,053
-379,642
-54% -$520K ﹤0.01% 4940
2025
Q2 		$759K Sell
696,695
-87,922
-11% -$90.5K ﹤0.01% 4622
2025
Q1 		$763K Buy
784,617
+188,328
+32% +$247K ﹤0.01% 4550
2024
Q4 		$883K Sell
596,289
-727,484
-55% -$1.48M ﹤0.01% 4301
2024
Q3 		$2.81M Buy
1,323,773
+213,475
+19% +$486K ﹤0.01% 3380
2024
Q2 		$2.71M Buy
1,110,298
+544,881
+96% +$2.62M ﹤0.01% 3265
2024
Q1 		$3.66M Buy
565,417
+121,058
+27% +$705K ﹤0.01% 3193
2023
Q4 		$1.72M Sell
444,359
-22,263
-5% -$56.9K ﹤0.01% 3729
2023
Q3 		$999K Sell
466,622
-392,625
-46% -$1.08M ﹤0.01% 4186
2023
Q2 		$2.62M Sell
859,247
-238,101
-22% -$670K ﹤0.01% 3245
2023
Q1 		$2.85M Buy
1,097,348
+259,046
+31% +$772K ﹤0.01% 3092
2022
Q4 		$1.72M Buy
838,302
+326,694
+64% +$855K ﹤0.01% 3692
2022
Q3 		$2.31M Buy
511,608
+262,691
+106% +$1.43M ﹤0.01% 3617
2022
Q2 		$1.02M Buy
248,917
+206,516
+487% +$942K ﹤0.01% 4345
2022
Q1 		$187K Buy
+42,401
New +$297K ﹤0.01% 5847

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Israel Englander's HOWL Position: Q2 2026 in Review

Israel Englander reduced its Werewolf Therapeutics (HOWL) stake by 53% in Q2 2026, selling an estimated $42.6K and leaving 62,055 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5684.

Israel Englander first reported a position in HOWL in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.66M in Q1 2024. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

  • Israel Englander held 62,055 shares of Werewolf Therapeutics worth $22.3K as of Q2 2026.
  • Israel Englander sold 69,995 Werewolf Therapeutics shares in Q2 2026, an estimated $42.6K.
  • Werewolf Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5684 holding.
  • Israel Englander first reported a position in Werewolf Therapeutics in Q1 2022 and has held it in 18 quarters since.
  • Israel Englander's Werewolf Therapeutics position peaked at $3.66M in Q1 2024.
  • 45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.